News
McKinsey & Company to pay $650 million to settle U.S. opioid consulting probe A former top partner at McKinsey has also agreed to plead guilty to obstruction of justice in the federal probe ...
McKinsey & Company, a consulting firm, has agreed to pay $650 million to settle a federal investigation into its work for opioids manufacturer Purdue Pharma, according to court papers filed in ...
McKinsey & Company agreed to pay $650 million in a deferred prosecution agreement that will resolve a federal criminal probe into the company’s consulting work advising Purdue Pharma on how to ...
McKinsey & Co. has agreed to pay $650 million to resolve a Justice Department investigation into the consulting firm’s work advising opioid manufacturer OxyContin maker Purdue Pharma on how to ...
McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work for opioids manufacturer Purdue Pharma, according to court papers filed in Vir… ...
WASHINGTON — McKinsey & Company, a consulting firm, has agreed to pay $650 million to settle a federal investigation into its work for opioids manufacturer Purdue Pharma, according to court ...
Consulting firm McKinsey & Co has agreed to pay $78 million to resolve claims by U.S. health insurers and benefit plans that it fueled an epidemic of opioid addiction through its work for drug ...
McKinsey & Company agreed to pay $650 million in a deferred prosecution agreement that will resolve a federal criminal probe into the company's consulting work ...
McKinsey & Company agrees to a $650 million settlement over its role in advising Purdue Pharma on opioid sales, avoiding criminal charges under specific conditions. Skip to content NOWCAST WPBF 25 ...
McKinsey & Company, a consulting firm, has agreed to pay $650 million to settle a federal investigation into its work for opioids manufacturer Purdue Pharma, according to court papers filed in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results